{"id":"W4409539789","doi":"10.2967/jnumed.124.269154","title":"FDA Approval of<sup>18</sup>F-Flurpiridaz for PET: Stepping into a New Era of Myocardial Perfusion Imaging?","year":2025,"lang":"en","type":"editorial","venue":"Journal of Nuclear Medicine","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Cardiovascular Society; Canadian Nuclear Safety Commission","funders":"National Institutes of Health; Sun Pharma; Siemens Healthineers; Amgen; Cardinal Health; Fondation Leducq; Gilead Sciences; Alnylam Pharmaceuticals; Cedars-Sinai Medical Center; National Heart, Lung, and Blood Institute; Pfizer; University of Ottawa; American Heart Association","keywords":"Myocardial perfusion imaging; Perfusion; Nuclear medicine; Perfusion scanning; Medicine; Medical physics; Radiology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007443062,0.001947304,0.002500201,0.001554484,0.001673606,0.004454506,0.002285546,0.01592439,0.006226663],"category_scores_gemma":[0.01630846,0.0009123233,0.001977816,0.0007330498,0.002018372,0.003831127,0.000685079,0.01882117,0.007271078],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002018637,"about_ca_system_score_gemma":0.002181279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000907461,"about_ca_topic_score_gemma":0.002572408,"domain_scores_codex":[0.9973201,0.000521113,0.0003817318,0.0002467543,0.001374578,0.000155709],"domain_scores_gemma":[0.988389,0.005323747,0.0007039698,0.000270197,0.004077373,0.001235697],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009911117,0.00002002002,0.00003802587,0.0002810195,0.00003414324,0.0002086494,0.00001386298,0.00002552792,0.0001555079,0.0004988075,0.9842509,0.01437446],"study_design_scores_gemma":[0.0001671697,0.00006903324,0.0002438153,0.0003681832,0.000103661,0.0003893366,0.00004186231,0.0001661263,0.000389217,0.001165177,0.9968737,0.00002265654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.0001751408,0.01901644,0.0003277102,0.08751821,0.88915,0.0000429014,0.00007911407,0.0001108899,0.003579605],"genre_scores_gemma":[0.00146801,0.01723628,0.0003787502,0.08812262,0.8779387,0.00004422002,0.0000656414,0.00006415985,0.01468163],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.01592439,"threshold_uncertainty_score":0.03936309,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009166549857517496,"score_gpt":0.2949035972662356,"score_spread":0.2857370474087181,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}